NEC OncoImmunity publishes research using its neoantigen prediction technology showing improved outcome in sarcoma patients treated with cancer immunotherapy

Source :: Business Wire. October 17, 2023
Publication Year :: 2023
Abstract: OSLO, Norway -- NEC OncoImmunity AS (NOI) today announced it has published a study that describes the use of its artificial intelligence (AI) based neoantigen prediction technology to demonstrate that [...]

Subjects :: Oncology, Experimental -- Technology application
Sarcoma -- Drug therapy -- Development and progression -- Patient outcomes
Cancer patients -- Drug therapy -- Patient outcomes
Immunotherapy -- Technology application
Cancer -- Care and treatment -- Development and progression -- Patient outcomes -- Drug therapy -- Research
Tumor antigens -- Technology application
Technology application
Business
Business, international

Tools